Drug profile · INN
somatropin [rdna origin]
NUTROPIN
somatropin [rdna origin] (NUTROPIN) is a growth hormone receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — somatropin [rdna origin]
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 3
- Data quality
- 0.84
Quick answer
somatropin [rdna origin] (NUTROPIN) is a growth hormone receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Growth hormone receptor agonist
Primary target: Growth hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is somatropin [rdna origin]?
somatropin [rdna origin] (NUTROPIN) is a growth hormone receptor agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for somatropin [rdna origin]?
NUTROPIN is a marketed brand name for somatropin [rdna origin]. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of somatropin [rdna origin]?
somatropin [rdna origin] has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.